Sartorius Stedim Biotech S.A. (ENXTPA:DIM) signed an agreement to acquire chromatography equipment division from Novasep Holding SAS on January 6, 2021. The transaction is subject to works council consultation, antitrust approvals and the approval of all relevant regulatory bodies. On February 1, 2022, the US FTC approved the transaction.

The transaction is expected to close during the first half of 2021. As of October 2021, The transaction is expected to close before the end of the year. Karl Hepp de Sevelinges, Michael Samol, Robert d'Orglandes, Laetitia Ternisien and Gabriel di Chiara of Jeantet & Associés acted as legal advisor to Sartorius Stedim in the transaction.

François Leloup, Delphin Boucher, Alexandre Jaurett, Rebecca Farrington, Alex Zhang, Michiel Visser and Orion Berg of White & Case LLP acted as legal advisor to Novasep Holding in the transaction. Michael Bernhardt and Alexander Rinne of Milbank LLP acted as legal advisor to Sartorius Stedim in the transaction. Graf von Westphalen Bappert Modest acted as legal advisor to Sartorius in the transaction.